QUALITY OF LIFE, INSULIN USE AND TYPE 2 DIABETES MELLITUS IN THE CITY OF CURITIBA – PR – PORTÃO DISTRICT

Authors

  • Caio Cesar Cervi Lagana Pontifícia Universidade Católica do Paraná - PUCPR
  • Natália Boing Salvatti Pontifícia Universidade Católica do Paraná - PUCPR
  • Rafaela Maria Zaions Pontifícia Universidade Católica do Paraná - PUCPR
  • Ricardo Batista Pontifícia Universidade Católica do Paraná - PUCPR
  • Roberto Augusto Schirr Pontifícia Universidade Católica do Paraná - PUCPR
  • Ana Cristina Ravazzani de Almeida Faria Pontifícia Universidade Católica do Paraná - PUCPR
  • Solena Ziemer Kusma Pontifícia Universidade Católica do Paraná - PUCPR

DOI:

https://doi.org/10.5380/rmu.v1i4.40691

Keywords:

Diabetes Mellitus, T2DM, Quality of Life, Insulin

Abstract

Introduction: Diabetes mellitus is a chronic disease characterized by impaired action and/or secretion of insulin that produces a profound impact in the quality of life of its bearers. Type 2 Diabetes Mellitus (T2DM) accounts for 85-95% of all cases, achieving its peak incidence in the sixth decade. Chronic complications can be avoided or delayed through a good glycemic control. Objective: To access the quality of life of type 2 diabetics in Portão district, in the city of Curitiba, by the means of a questionnaire, and to confront this data with the use of insulin. Methods:  This is a cross-sectional study. The sample consists of 156 type 2 diabetic patients over 18 years, enrolled in Basic Health Units and Units of Family Health Strategy in the District of Portão, Curitiba-PR. The instrument used in the research was based on a questionnaire entitled the Diabetes Quality of Life Measures (DQOL – Brazil). There were multiple-choice objective questions about the aspects of the disease, personal satisfaction, impact on social and vocational concerns and those related to T2DM. Results: 67,2% were female, 58,9% had more than 60 years old and 46,9% were retired. Treatment with insulin associated or not with oral drugs was used by 37,2% of the sample. Glycated hemoglobin mean value was 7,96% and 80,8% were unaware of its purpose. All sections of DQOL were statistically significant (p<0,05) and revealed higher dissatisfaction scores on those who used insulin. Conclusion: Pacients with T2DM who use insulin have inferior results considering quality of life when compared to those who didn’t start insulin therapy. The use of insulin was considered an independent factor that influences negatively the quality of life of type 2 diabetics in Portão district in Curitiba-PR.

References

Diretrizes da Sociedade Brasileira de Diabetes 2009/Sociedade brasileira de diabetes. 3ª Ed. Itapevi, SP: A. Araújo Silva Farmacêutica, 2009.

International Diabetes Federation. Diabetes Atlas. Fourth edition. 2010.

Gross JL, Silveiro SP, Camargo JL, Reichelt AJ, Azevedo MJ. Diabetes Melito: Diagnóstico, Classificação e Avaliação do Controle Glicêmico. Arq Bras Endocrinol Metab. Fevereiro/2002; 46(1):16-26

Ministério da Saúde (Br). Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Diabetes Mellitus. Brasília (DF): Ministério da Saúde; 2006.

European Association Study of Diabetes. Diabetes evidence demands real action from the UN Summit on Non-communicable diseases. Disponível em: http://www.easd.org/easdwebfiles/annualmeeting/47thmeeting/Prog/Press/Releases/IDF_press_notice.pdf. Acesso em 27 de outubro de 2011.

Boyle et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Population Health Metrics 2010 8:29

American Diabetes Association. Standard of Medical Care in Diabetes - 2011. Diabetes Care 2011; 34(1):11-61

DCCT and EDIC: The diabetes control and complications trial and follow-up study.NIH Publication No. 08-3874 May 2008.

Gardner DG, Shoback D. Greenspan’s basic and clinical endocrinology. 9th ed. New York: McGraw-Hill, 2011.

Grupo Interdisciplinar de Padronização da Hemoglobina Glicada – A1C. Atualização sobre hemoglobina glicada (A1C) para avaliação do controle glicêmico e para o diagnóstico do diabetes: aspectos clínicos e laboratoriais. Disponível em: http://www.diabetes.org.br/attachments/502_posicionamentos_SBD_3_jan09.pdf. Acesso em 31 de outubro de 2011.

King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Blackwell Science Ltd Br j Clin Pharmacol 1999; 48: 643-648.

The WHOQoL Group. The development of the World Health Organization quality of life assessment instrument (the WHOQOL). In: Orley J, Kuyken W, editores. Quality of life assessment: international perspectives. Heidelberg: Springer Verlag; 1994. p. 41-60.

Castro CLN, Braulio VB, Dantas FAL, Couto APCB. Qualidade de vida em diabetes mellitus e Classificação Internacional de Funcionalidade, Incapacidade e Saúde - estudo de alguns aspectos. Acta Fisiatr 2008; 15(1): 13-17

Kalda R, Rätsep A, Lember M. Predictors of quality of life of patients. with type 2 diabetes. Patient Pref Adherence 2008; 2:21-6

Correr et al. Tradução para o Português e Validação do Instrumento Diabetes Quality of Life Measure (DQOL-Brasil). Arq Brás Endocrinol Metab 2008; 52(3): 515-22

Aguiar CCT et al. Instrumentos de Avaliação de Qualidade de Vida Relacionada à Saúde no Diabetes Melito. Arq Bras Endocrinol Metab 2008; 52(6): 931-9

Downloads

How to Cite

Lagana, C. C. C., Salvatti, N. B., Zaions, R. M., Batista, R., Schirr, R. A., Faria, A. C. R. de A., & Kusma, S. Z. (2014). QUALITY OF LIFE, INSULIN USE AND TYPE 2 DIABETES MELLITUS IN THE CITY OF CURITIBA – PR – PORTÃO DISTRICT. Revista Médica Da UFPR, 1(4), 150–155. https://doi.org/10.5380/rmu.v1i4.40691

Issue

Vol. 1 No. 4 (2014)

Section

Artigos Originais

License

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).